在法布里病患者的补充激活和细胞炎症,尽管酶替代疗法治疗
Björn Laffer1, Malte Lenders2, Elvira Ehlers-Jeske1
1Institute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany.
Frontiers in immunology
|February 2, 2024
概括
费布里病 (FD) 涉及有缺陷的α-galactosidase A,导致糖脂积累和器官损伤. 这项研究表明,在FD患者中,补体系统的激活强烈,特别是那些具有无意义突变和抗药抗体的人,这表明尽管治疗,炎症仍然存在.
科学领域:
- 生物化学 生化学
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 费布里病 (FD) 由缺陷的α-galactosidase A (AGAL/GLA) 引起,导致葡萄糖脂积累 (Gb3,lyso-Gb3) 和慢性炎症.
- 使用agalsidase-alfa/-beta的酶替代疗法 (ERT) 有助于Gb3清除,但其对FD补体激活的影响尚不清楚.
研究的目的:
- 调查ERT前后的经典男性FD患者的补充系统激活.
- 在FD治疗期间探索突变类型,抗药抗体 (ADA) 和补充激活/细胞因子概况之间的关系.
主要方法:
- 血清中C3a,C5a,IL-6,IL-10和TGF-β1的水平在17名经典男性FD患者中测量.
- 根据突变类型 (错误与无意义) 和ERT状态,包括ADA发展,分析了患者.
主要成果:
- 在FD患者中观察到强烈的补充激活 (升高的C3a,C5a),独立于ERT.
- 具有无意义突变和ADA的FD患者在ERT下显示C3a/C5a增加,而非ADA负误解突变患者.
- 发现IL-6,IL-10和TGF-β1的升高,特别是在ERT治疗的误解突变患者中,与轻度脏病相关.
结论:
- 补体系统激活是FD的一个重要特征,特别是在具有无意义突变和ADA的男性中.
- 细胞相关的细胞因子生产可能会导致FD的损伤,这表明尽管ERT,但炎症是治疗的目标.
相关概念视频
Complement System
2.4K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.4K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K


